# First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II)

> **NCT01960504** · NA · UNKNOWN · sponsor: **Biotronik AG** · enrollment: 123 (actual)

## Conditions studied

- Coronary Artery Disease
- Coronary Artery Stenosis

## Interventions

- **DEVICE:** Percutaneous Coronary Intervention (DREAMS) stenting

## Key facts

- **NCT ID:** NCT01960504
- **Lead sponsor:** Biotronik AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2015-08
- **Final completion:** 2020-05
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01960504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01960504, "First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01960504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*